-
1
Effects of sodium-glucose cotransporter-2 inhibitors on chronic kidney disease progression: a multi-state survival model
Published 2024-11-01Subjects: “…Sodium-glucose cotransporter-2 inhibitors…”
Get full text
Article -
2
The role of sodium – glucose cotransporter-2 inhibitors in the treatment of different phenotypes of chronic heart failure
Published 2024-03-01Subjects: “…sodium-glucose cotransporter-2 inhibitors…”
Get full text
Article -
3
Sodium-glucose cotransporter-2 inhibitors increase urinary tract infections?—a cross sectional analysis of a nationwide Japanese claims database
Published 2023-11-01Subjects: “…sodium-glucose cotransporter-2 inhibitor…”
Get full text
Article -
4
Effects of sodium-glucose cotransporter-2 inhibitor on atrial high-rate episodes in patients with cardiovascular implantable electronic device: a randomized controlled trial
Published 2024-11-01Subjects: “…Sodium-glucose Cotransporter-2 inhibitor…”
Get full text
Article -
5
Association of sodium–glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis
Published 2025-01-01Subjects: “…Sodium–glucose cotransporter-2 inhibitors…”
Get full text
Article -
6
Empagliflozin Attenuates High-Glucose-Induced Astrocyte Activation and Inflammation via NF-κB Pathway
Published 2024-11-01Subjects: “…sodium-glucose cotransporter 2 inhibitor…”
Get full text
Article -
7
SGLT2 inhibitors for alleviating heart failure through non-hypoglycemic mechanisms
Published 2024-12-01Subjects: “…sodium-glucose cotransporter-2 inhibitor…”
Get full text
Article -
8
Sodium-glucose cotransporter 2 inhibition in patients with liver cirrhosis and diabetes: a possible role in ascites control?
Published 2024-11-01Subjects: Get full text
Article -
9
Impact of SGLT2 inhibitors on cardiovascular outcomes and metabolic events in Chinese han patients with chronic heart failure
Published 2024-12-01Subjects: Get full text
Article -
10
The road ahead: emerging therapies for primary IgA nephropathy
Published 2025-02-01Subjects: “…SGLT2 (sodium-glucose cotransporter 2) inhibitor…”
Get full text
Article -
11
Effect of Sodium–Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes in Patients with Acute Coronary Syndrome and Type 2 Diabetes
Published 2024-11-01Subjects: “…sodium-glucose cotransporter 2 inhibitors…”
Get full text
Article -
12
Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report
Published 2025-01-01Subjects: Get full text
Article -
13
-
14
-
15
The association between sodium–glucose cotransporter 2 inhibitors and contrast-associated acute kidney injury in patients with type 2 diabetes undergoing angiography: a propensity-...
Published 2024-12-01Subjects: “…Sodium–glucose cotransporter 2 inhibitor…”
Get full text
Article -
16
Sodium‐glucose cotransporter‐2 inhibitors in heart failure: an updated meta‐analysis
Published 2022-06-01Subjects: Get full text
Article -
17
Effect of sodium glucose cotransporter 2 inhibitors on all cause death and rehospitalization for heart failure in patients with acute myocardial infarction
Published 2024-12-01Subjects: “…Sodium-glucose cotransporter-2 inhibitors…”
Get full text
Article -
18
-
19
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Body Composition and Fluid Status in Cardiovascular Rehabilitation Patients with Coronary Artery Disease and Heart Failure
Published 2024-12-01Subjects: “…sodium glucose cotransporter-2 inhibitors…”
Get full text
Article -
20
Comparative Analysis of the Influence of Empagliflozin and Dapagliflozin on the Course of Heart Failure with Associated Pathology
Published 2024-12-01Subjects: Get full text
Article